Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thymoma × Histocompatibility Testing × Thoracic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Lung Neoplasms 2 Thymus Neoplasms 1 Thymoma 1 Mesothelioma 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Adenocarcinoma 1

Interventions

Cyclophosphamide 6 Cisplatin 6 pembrolizumab 5 Sunitinib 5 Radiotherapy 5 Carboplatin 5 Paclitaxel 4 130-nm albumin-bound paclitaxel 3 selinexor 2 Thymectomy 2 Taxes 2 Robotic Surgical Procedures 2 Ramucirumab 2 Prednisone 2 Pemetrexed 2 Octreotide 2 N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 2 Imatinib Mesylate 2 Etoposide 2 Erlotinib Hydrochloride 2 Drug Therapy 2 Doxorubicin 2 Chemoradiotherapy 2 Celecoxib 2 zimberelimab 1 saracatinib 1 regorafenib 1 olaparib 1 lenvatinib 1 isophosphamide mustard 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04162691 2023-01-13

Single Cell Sequencing Analysis of Thymoma

Zhejiang Cancer Hospital

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡